TissueTech raises $10M for regenerative medicine businesses

08/23/2013 | MassDevice.com (Boston)

TissueTech has secured $10 million in financing from River Cities Capital Funds and Ballast Point Ventures. The Doral, Fla.-based company will use the money to support research and development as well as fund the commercialization of regenerative medicine products developed by its Amniox Medical and Bio-Tissue units.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA